Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|September 28, 2021
Oral Semaglutide, the First Ingestible Glucagon-Like Peptide-1 Receptor Agonist: Could It Be a Magic Bullet for Type 2 Diabetes?Hwi Seung Kim, Chang Hee Jung
Diabetes & Metabolism Journal|February 4, 2021
Dulaglutide as an Effective Replacement for Prandial Insulin in Kidney Transplant Recipients with Type 2 Diabetes Mellitus: A Retrospective ReviewHwi Seung Kim, Jiwoo Lee, Chang Hee Jung, et al.
Diabetes/Metabolism Research and Reviews|May 6, 2021
Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real-world data studyJiwoo Lee, Hwi Seung Kim, Chang Hee Jung, et al.
Diabetes & Metabolism Journal|November 8, 2021
Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World StudyHwi Seung Kim, Taekwan Yoon, Chang Hee Jung, et al.
Clinical Therapeutics|July 28, 2024
One-year Efficacy and Safety of Dulaglutide in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Study of Asian PatientsMyung Jin Kim, Hwi Seung Kim, Yun Kyung Cho, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 23, 2020
Clinical Efficacy of Quadruple Oral Therapy for Type 2 Diabetes in Real-World Practice: A Retrospective Observational StudyYun Kyung Cho, Jiwoo Lee, Hwi Seung Kim, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|January 11, 2020
Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World PracticeJiwoo Lee, Yun Kyung Cho, Hwi Seung Kim, et al.
Frontiers in Endocrinology|November 17, 2022
Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data studyHwi Seung Kim, Yun Kyung Cho, Myung Jin Kim, et al.
Clinical Endocrinology|December 12, 2025
Real-World Evidence of Long-Term Dulaglutide Use: Sustained Glycemic and Weight Improvements Beyond Three YearsHwi Seung Kim, Myung Jin Kim, Hee Sung Kim, et al.
Journal of Lipid and Atherosclerosis|June 3, 2022
Triglyceride-Glucose Index Is a Useful Marker for Predicting Future Cardiovascular Disease and Mortality in Young Korean Adults: A Nationwide Population-Based Cohort StudyYun Kyung Cho, Kyung-do Han, Hwi Seung Kim, et al.
Pageof 4